← Leaderboards
Kenneth O Willeford
Genebact Biotechnologies, Inc.
$133,634
Attributed
$133,634
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$133,634 · 1
By mechanism
R43$133,634 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antibacterial Agents”
- Samuel L. Stanley · Washington University$43,109,831
- Henry F Chambers · Duke University$36,736,079
- Vance G Fowler · Duke University$36,735,128
- Richard H. Ebright · Rutgers The St Univ Of Nj New Brunswick$26,236,829
- Bruce Blough · Research Triangle Institute$19,637,160
- Ramnik J Xavier · Broad Institute, Inc.$15,975,908
Research focus
Antibacterial AgentsAntiviral AgentsBacterial DiseaseBacterial VaccinesBioassayBiological Response ModifiersBioterrorism /Chemical WarfareBlood LipoproteinDrug Design /Synthesis /ProductionDrug Discovery /IsolationDrug PreservationDrug Screening /EvaluationImmunologic MemoryImmunomodulatorsLaboratory MouseLaboratory RatPathologic ProcessScintillation CounterViral VaccinesVirus Diseases